Results 171 to 180 of about 128,906 (193)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 2019
Key Clinical Points Helicobacter pylori Infection Testing for H. pylori is recommended in patients with peptic ulcer disease, gastric cancer, or gastric mucosa–associated lymphoid tissue lymphoma (...
David Y, Graham +2 more
openaire +5 more sources
Key Clinical Points Helicobacter pylori Infection Testing for H. pylori is recommended in patients with peptic ulcer disease, gastric cancer, or gastric mucosa–associated lymphoid tissue lymphoma (...
David Y, Graham +2 more
openaire +5 more sources
Current Opinion in Internal Medicine, 2002
Current standard treatment regimens for Helicobacter pylori infection provide eradication rates 80 to 90%. These rates have been achieved with a variety of 1-week triple therapies using two antibiotics and an acid suppressant. Antibiotic resistance, which may develop during failed treatment, is becoming increasingly common and has led to studies of new
Lila, Belhoussine-Idrissi +1 more
openaire +2 more sources
Current standard treatment regimens for Helicobacter pylori infection provide eradication rates 80 to 90%. These rates have been achieved with a variety of 1-week triple therapies using two antibiotics and an acid suppressant. Antibiotic resistance, which may develop during failed treatment, is becoming increasingly common and has led to studies of new
Lila, Belhoussine-Idrissi +1 more
openaire +2 more sources
Helicobacter pylori infection: pathogenesis
Current Opinion in Gastroenterology, 2002Helicobacter pylori is known to be the cause of most gastric diseases, including both peptic ulcer disease and gastric cancer. In the absence of eradication, infection tends to be lifelong and the immune response ineffective in clearing the bacteria. A number of groups have investigated whether the immune clearance of infection can be achieved through ...
James G, Fox, Timothy C, Wang
openaire +2 more sources
Helicobacter pylori infection: pathogenesis
Current Opinion in Gastroenterology, 2003This review covers progress in identifying Helicobacter pylori-derived factors that are involved in survival and virulence of the organism and in elucidating host response pathways that can limit the infection but are also susceptible to dysregulation.
Purvi C, Panchal +3 more
openaire +2 more sources
Management ofHelicobacter pyloriinfection
Expert Review of Anti-infective Therapy, 2010Helicobacter pylori is the cause of peptic ulcer, gastric cancer and gastric lymphoma. Diagnosis of H. pylori infection can be made using invasive and noninvasive tests. Invasive tests based on endoscopy, such as histology, are recommended when a gastric malignancy is suspected.
F. Costa, D'ELIOS, MARIO MILCO
openaire +4 more sources
Diagnosis of Helicobacter pylori infection
BMJ, 2012The article explores how to test for Helicobacter pylori infection and when to check whether treatment has ...
openaire +3 more sources
Helicobacter pylori infection.
BMJ clinical evidence, 2016The principal effect of Helicobacter pylori infection is lifelong chronic gastritis, affecting up to 20% of younger adults but 50% to 80% of adults born in resource-rich countries before 1950.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of H pylori eradication treatment in people with a ...
Grigorios I, Leontiadis +2 more
openaire +1 more source
Helicobacter pylori infection.
Postgraduate medicinePreview Since the discovery of Helicobacter pylori 10 years ago, its role in peptic ulcer disease has been recognized. Now the questions are, What is the best way to eradicate the organism, and which patients should receive treatment? Dr Anderson explores the issues concerning H pylori infection in patients with recurrent ulcers and describes the most ...
+6 more sources
Healing of duodenal ulcer after eradication of Helicobacter heilmannii
Lancet, The, 1997Robin Spiller
exaly